−4.0840USD
−30.15 MUSD
7.64 M
About NRX Pharmaceuticals, Inc.
Sector
CEO
Stephen H. Willard
Headquarters
Wilmington
Website
Founded
2017
FIGI
BBG00JCWDKV1
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
